retatrutide side effects phase 2 trial Triple Agonist Associated with Weight Loss of up to 24% in 48-Week retatrutide clinical trial safety data

Imagine a world where staying healthier is easier than staying unhealthy

Gudzune, K

Contraindications Absolute contraindications I never compromise on: Current opioid medication use (LDN will block their effectiveness) Severe liver disease Pregnancy and breastfeeding (insufficient safety data) Relative contraindications requiring careful consideration: Organ transplant recipients taking immunosuppressive medications Active cancer treatment How I Monitor Success Success with Low Dose Naltrexone encompasses both measurable improvements and patient-reported changes: What I track: Reduced inflammatory markers (ESR, CRP), improved functional scores, decreased need for pain medications

As we age and thanks to stress, pollution, poor sleep, and lifestyle habits glutathione levels drop

While some improvements were noted, they werent statistically consistent